Overview of Dr. Knisely
Dr. Jonathan Knisely is a radiation oncologist in New York, NY and is currently affiliated with New York-Presbyterian Hospital. He previously worked at the Yale University School of Medicine and at Northwell Health after completing his radiation oncology residency at the University of Toronto and an internal medicine residency at Michael Reese Hospital. He has lifetime board certification in both Internal Medicine and Radiation Oncology. He received his medical degree from the University of Pennsylvania. He has been in practice for 31 years . He speaks Chinese (Mandarin). He specializes in benign diseases and central nervous system cancer and is extremely experienced in brain tumor radiotherapy and stereotactic radiosurgery.
Office
1283 York Avenue
4th Floor
New York, NY 10065
Clinical Expertise
- Stereotactic radiosurgery, Intensity-modulated radiation therapy, Radiosurgery, Stereotactic body radiotherapy, Brain cancer, Brain tumor radiotherapy
Education & Training
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1986 - 1989
- Perelman School of Medicine at the University of PennsylvaniaClass of 1986
Certifications & Licensure
- FL State Medical License 2022 - Present
- NY State Medical License 2011 - 2026
- CT State Medical License 1992 - 2013
- IL State Medical License 1986 - 1989
- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2008-2011, 2013-2021
- America's Top Doctors for Cancer Castle Connolly, 2005-2010, 2012-2013, 2016-2021
- FASTRO Fellow, American Society for Radiation Oncology, 2017
- Join now to see all
Publications & Presentations
PubMed
- [18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastases.Jana Ivanidze, Arman Sharbatdaran, Aliah McCalla, Andrew Brandmaier, Eleni Andreopoulou
European Journal of Radiology. 2024-12-01 - An update to the American Radium Society's appropriate use criteria of lower grade gliomas: Integration of IDH inhibitors.Martin C Tom, Seema Nagpal, Joshua D Palmer, William G Breen, Erqi L Pollom
Radiotherapy and Oncology. 2024-11-16 - PSMA PET improves characterization of dural-based intracranial lesions in patients with metastatic prostate cancer.Divya Yadav, Silvina P Dutruel, Elisabeth O'Dwyer, Andres Ricaurte-Fajardo, Rituraj Upadhyay
European Journal of Radiology. 2024-11-01
Press Mentions
- Some Brain Cancer Patients Have Radiation Options: StudyJuly 26th, 2016
Professional Memberships
- American Radium SocietyMember
- Radiosurgery SocietyMember
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: